Teachers Retirement System of The State of Kentucky Sells 8,681 Shares of Encompass Health Co. (NYSE:EHC)

Teachers Retirement System of The State of Kentucky lowered its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 18.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,325 shares of the company's stock after selling 8,681 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Encompass Health were worth $3,539,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in EHC. Miracle Mile Advisors LLC increased its position in shares of Encompass Health by 3.0% during the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock worth $354,000 after purchasing an additional 112 shares in the last quarter. US Bancorp DE increased its holdings in shares of Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after buying an additional 121 shares in the last quarter. Signaturefd LLC boosted its holdings in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after acquiring an additional 125 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Trading Up 0.1 %

Shares of Encompass Health stock traded up $0.08 during trading on Tuesday, reaching $115.40. 293,450 shares of the company were exchanged, compared to its average volume of 676,522. The business has a 50-day moving average price of $100.35 and a 200-day moving average price of $98.71. The firm has a market capitalization of $11.62 billion, a price-to-earnings ratio of 25.86, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a twelve month low of $82.38 and a twelve month high of $116.20.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The company had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same period in the prior year, the business posted $1.12 EPS. Encompass Health's revenue was up 10.6% on a year-over-year basis. Sell-side analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.59%. The ex-dividend date was Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Analysts Set New Price Targets

Several analysts have recently commented on EHC shares. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Friday. Truist Financial restated a "buy" rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research report on Monday. Barclays upped their target price on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday. UBS Group boosted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday. Finally, Royal Bank of Canada increased their price objective on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $120.86.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.